GT Medical Technologies Announces First Patient Enrolled in GESTALT Trial of GammaTile(R) Therapy for Newly Diagnosed Glioblastoma Brain Tumors
This phase 4 clinical trial evaluates the use of GammaTile Therapy at the time of surgery combined with the standard Stupp protocol for patients with newly diagnosed glioblastomas.
TEMPE, Ariz., Oct. 11, 2022 -- (Healthcare Sales & Marketing Network) -... Devices, Oncology, Neurosurgery GT Medical Technologies, GammaTile, Surgically Targeted Radiation Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Marketing | Neurology | Neurosurgery | Pharmaceuticals | Radiation Therapy